- Home
- TLSI vs BNC Comparison
TLSI vs BNC Comparison
Compare TLSI & BNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TLSI | BNC |
|---|---|---|
| Founded | 2010 | N/A |
| Country | United States | United States |
| Employees | 110 | N/A |
| Industry | Medical Specialities | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 267.1M | 287.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TLSI | BNC |
|---|---|---|
| Price | $4.25 | $2.69 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | 190.8K | ★ 222.7K |
| Earning Date | 05-14-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $36.47 | N/A |
| Revenue Next Year | $39.31 | N/A |
| P/E Ratio | ★ N/A | $0.22 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.42 | $2.51 |
| 52 Week High | $7.95 | $31.62 |
Technical Indicators
Market Signals| Indicator | TLSI | BNC |
|---|---|---|
| Relative Strength Index (RSI) | 49.11 | 29.30 |
| Support Level | $3.79 | N/A |
| Resistance Level | $5.33 | $4.14 |
| Average True Range (ATR) | 0.24 | 0.21 |
| MACD | 0.06 | 0.00 |
| Stochastic Oscillator | 81.82 | 16.51 |
Price Performance
Historical ComparisonAbout TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About BNC CEA Industries Inc.
CEA Industries Inc through its subsidiary is focused on selling environmental control and other technologies and services to the Controlled Environment Agriculture ("CEA") industry. The company provides integrated mechanical, electrical, and plumbing ("MEP") engineering design, proprietary and curated environmental control equipment, and automation offerings that serve the CEA industry. The Company has one operating segment that is dedicated to the manufacture and sale of its products.